The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Matsko D.E.

Zrelov A.A.

Polenov’s neurosurgery institute — the branch of V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russia;
North-Western State Medical University n. a. I.I. Mechnikov, Saint-Petersburg, Russia

Ulitin A.Yu.

Polenov Neurosurgical Institute, a branch of the Almazov National Medical Research Centre under the Ministry of Health of the Russia 12 Mayakovsky str., Saint Petersburg, Russia, 191014

Matsko M.V.

Polenov’s neurosurgery institute — the branch of V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russia;
Saint-Petersburg Clinical Research Center Specialized Types of Medical Care, Saint-Petersburg, Russia;
Saint-Petersburg State University, Saint-Petersburg, Russia;
Saint-Petersburg Medico-Social Institute, Saint-Petersburg, Russia

Skliar S.S.

Polenov’s neurosurgery institute — the branch of V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russia

Baksheeva A.O.

Polenov’s neurosurgery institute — the branch of V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russia;
North-Western State Medical University n. a. I.I. Mechnikov, Saint-Petersburg, Russia

Imianitov E.N.

NII onkologii im. N.N. Petrova, Sankt-Peterburg

Gemistocytic astrocytomas

Authors:

Matsko D.E., Zrelov A.A., Ulitin A.Yu., Matsko M.V., Skliar S.S., Baksheeva A.O., Imianitov E.N.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2018;80(4): 27‑38

DOI: 10.17116/patol201880427

Read: 6051 times

Download PDF (RU)
Contact the author
Table of contents

GEMISTOCYTIC ASTROCYTOMAS
GEMISTOCYTIC ASTROCYTOMAS

To cite this article:

Matsko DE, Zrelov AA, Ulitin AYu, Matsko MV, Skliar SS, Baksheeva AO, Imianitov EN. Gemistocytic astrocytomas. Russian Journal of Archive of Pathology. 2018;80(4):27‑38. (In Russ.)
https://doi.org/10.17116/patol201880427

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Gemistocytic astrocytomas (GA) are a variant of diffuse astrocytomas GII (WHO, 2016). Like all diffuse astrocytomas, GA recur with time, which is often accompanied by malignant degeneretion into the anaplastic astrocytoma GIII or to the secondary glioblastoma GIV. However, the progression-free survival and overall survival in patients with GA is less than in patients with diffuse astrocytomas. Given that this group of patients, according to the WHO classification (2016), is classified as GII, patients with GA usually do not receive comprehensive treatment. We have conducted a thorough analysis of research on this problem for the period from 1956 to 2017. Differences in the histological pattern, immunohistochemical and molecular-genetic profiles, survival of patients with GA and diffuse astrocytomas GII are shown there. A clinical case of a patient with transformation of a diffuse astrocytoma in GA (GIII) and then into a secondary glioblastoma is presented.

Keywords:

gemistocytic astrocytoma
diffuse astrocytoma
molecular-genetic features

Authors:

Matsko D.E.

Zrelov A.A.

Polenov’s neurosurgery institute — the branch of V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russia;
North-Western State Medical University n. a. I.I. Mechnikov, Saint-Petersburg, Russia

Ulitin A.Yu.

Polenov Neurosurgical Institute, a branch of the Almazov National Medical Research Centre under the Ministry of Health of the Russia 12 Mayakovsky str., Saint Petersburg, Russia, 191014

Matsko M.V.

Polenov’s neurosurgery institute — the branch of V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russia;
Saint-Petersburg Clinical Research Center Specialized Types of Medical Care, Saint-Petersburg, Russia;
Saint-Petersburg State University, Saint-Petersburg, Russia;
Saint-Petersburg Medico-Social Institute, Saint-Petersburg, Russia

Skliar S.S.

Polenov’s neurosurgery institute — the branch of V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russia

Baksheeva A.O.

Polenov’s neurosurgery institute — the branch of V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russia;
North-Western State Medical University n. a. I.I. Mechnikov, Saint-Petersburg, Russia

Imianitov E.N.

NII onkologii im. N.N. Petrova, Sankt-Peterburg

Close metadata

References:

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO classification of tumours of the central nervous system. 4-th ed. Lyon: IARC; 2016.
  2. Nissl F. Zur histopathologie der paralytischen Rindenerkrankung. Histologische und histopathologische Arbeiten über die Grosshirnrinde mit besonderer Berücksichtigung der pathologischen Anatomie der Geisteskrankheiten. Jena: G. Fischer; 1904;1:315-494.
  3. Elvidge AR, Penfield W, Cone W. The gliomas of the central nervous system. A study of 210 verified cases. Proc Assoc Res Nerv Ment Dis. 1937;16:107-181.
  4. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64(6):479-489. https://doi.org/10.1093/jnen/64.6.479
  5. Krouwer HGJ, Davis RL, Silver P, Prados M. Gemistocytic astrocytomas: a reappraisal. J Neurosurg. 1991;74(3):399-406. https://doi.org/10.3171/jns.1991.74.3.0399
  6. Okamoto Y, Di Patre P-L, Burkhard C, Horstmann S, Jourde B, Fahey M, Schüler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol. 2004;108(1):49-56. https://doi.org/10.1007/s00401-004-0861-z
  7. Ohta T, Kim Y-H, Oh J-E, Satomi K, Nonoguchi N, Keyvani K, Pierscianek D, Sure U, Mittelbronn M, Paulus W, Vital A, Yokoo H, McDonald K, Kleihues P, Nazaret N, Barbet F, Lachuer J, Ohgaki H. Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas. J Neuropathol Exp Neurol. 2014;73(10): 908-915. https://doi.org/10.1097/NEN.0000000000000110
  8. Yang HJ, Kim JE, Paek SH, Chi JG, Jung H-W, Kim DG. The significance of gemistocytes in astrocytoma. Acta Neurochir. (Wien). 2003;145(12):1097-1103. https://doi.org/10.1007/s00701-003-0149-4
  9. Jung TY, Jung S, Moon JH, Kim IY, Moon KS, Jang WY. Early prognostic factors related to progression and malignant transformation of low-grade gliomas. Clin Neurol Neurosurg. 2011; 113(9):752-757. https://doi.org/10.1016/j.clineuro.2011.08.002
  10. Babu R, Bagley JH, Park JG, Friedman AH, Adamson C. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology: Clinical article. J Neurosurg. 2013;119(2):434-441. https://doi.org/10.3171/2013.4.JNS122329
  11. Martins DC, Malheiros SM, Santiago LH, Stávale JN. Gemistocytes in astrocytomas: Are they a significant prognostic factor? J Neurooncol. 2006;80(1):49-55. https://doi.org/10.1007/s11060-006-9149-6
  12. Tihan T, Vohra P, Berger MS, Keles GE. Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective. J Neurooncol. 2006;76(2):175-183. https://doi.org/10.1007/s11060-005-4897-2
  13. Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H. Role of gemistocytes in astrocytoma progression. Lab Invest. 1997;76(2):277-284.
  14. Ohgaki H, Watanabe K, Peraud A, Biernat W, von Deimling A, Yasargil MG, Yonekawa Y, Kleihues P. A case history of glioma progression. Acta Neuropathol. 1999;97(5):525-532. https://doi.org/10.1007/s004010051024
  15. Burger PC, Scheithauer BW. Tumors of the central nervous system (AFIP Atlas of Tumor Pathology. Series 4. Fascicle 7). Washington, DC: American Registry of Pathology; 2007.
  16. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry. 1998;64(5):581-587.
  17. Heo YJ, Park JE, Kim HS, Lee JY, Nam SJ, Jung SC, Choi CG, Kim SJ. Prognostic relevance of gemistocytic grade II astrocytoma: gemistocytic component and MR imaging features compared to non-gemistocytic grade II astrocytoma. Eur Radiol. 2017;27(7): 3022-3032. https://doi.org/10.1007/s00330-016-4649-z
  18. Abe K, Hasegawa H, Kobayashi Y, Fujimura H, Yorifuji S, Bitoh S. A gemistocytic astrocytoma demonstrated high intensity on MR images. Protein hydration layer. Neuroradiology. 1990;32(2): 166-167. https://doi.org/10.1007/BF00588571
  19. Absalyamova OV, Anikeeva OYu, Golanov AV, Kobyakov GL, Konovalov AN, Kornienko VN, Krivoshapkin AL, Loshakov VA, Olyushin VE, Potapov AA, Ryzhova MV, Tanyashin SV, Trunin YuYu, Ulitin AYu, Shishkina LV. Klinicheskie rekomendatsii po lecheniyu pervichnykh opukholei tsentral’noi nervnoi sistemy. M.: Assotsiatsiya neirokhirurgov Rossii; 2013. (In Russ.) http://www.ruans.org/Files/Pdf/Guidelines/tumors.pdf
  20. Takeuchi J, Barnard RO. Perivascular lymphocytic cuffing in astrocytomas. Acta Neuropathol. 1976;35(3):265-271.
  21. Ridley A, Cavanagh JB. Lymphocytic infiltration in gliomas: evidence of possible host resistance. Brain. 1971;94(1):117-124.
  22. Böker DK, Kalff R, Gullotta F, Weekes-Seifert S, Möhrer U. Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma. Clin Neuropathol. 1984;3(4):143-147.
  23. Hoshino T, Wilson BC, Ellis WG. Gemistocytic astrocytes in gliomas. An autoradiographic study. J Neuropathol Exp Neurol. 1975;34(3):263-281. https://doi.org/10.1097/00005072-197505000-00004
  24. Kros JM, Schouten WC, Janssen PJ, van der Kwast TH. Proliferation of gemistocytic cells and glial fibrillary acidic protein (GFAP)-positive oligodendroglial cells in gliomas: a MIB-1/GFAP double labeling study. Acta Neuropathol. 1996;91(1):99-103.
  25. Kros JM, Stefanko SZ, de Jong AA, van Vroonhoven CC, van der Heul RO, van der Kwast TH. Ultrastructural and immunohistochemical segregation of gemistocytic subsets. Hum Pathol. 1991; 22(1):33-40. https://doi.org/10.1016/0046-8177(91)90058-W
  26. Reis RM, Hara A, Kleihues P, Ohgaki H. Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas. Acta Neuropathol. 2001;102(5):422-425. https://doi.org/10.1007/s004010100452
  27. Avninder S, Sharma MC, Deb P, Mehta VS, Karak AK, Mahapatra AK, Sarkar C. Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations — a study of 32 cases. J Neurooncol. 2006;78(2):123-127. https://doi.org/10.1007/s11060-005-9077-x
  28. Kösel S, Scheithauer BW, Graeber MB. Genotype-phenotype correlation in gemistocytic astrocytomas. Neurosurgery. 2001; 48(1):187-193, discussion 193-194. https://doi.org/10.1097/00006123-200101000-00033
  29. Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H. p53 and PTEN gene mutations in gemistocytic astrocytomas. Acta Neuropathol. 1998;95(6):559-564. https://doi.org/10.1007/s004010050840
  30. Hilton DA, Love S, Barber R, Ellison D, Sandeman DR. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy. Neurosurgery. 1998;42(4):724-729. https://doi.org/10.1097/00006123-199804000-00021
  31. Tamiya T, Mizumatsu S, Ono Y, Abe T, Matsumoto K, Furuta T, Ohmoto T. High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas. Acta Neuropathol. 2001; 101(4):334-340. https://doi.org/10.1007/s004010000261
  32. Piva R, Cavalla P, Bortolotto S, Cordera S, Richiardi P, Schiffer D. p27/kip1 expression in human astrocytic gliomas. Neurosci Lett. 1997;234(2-3):127-130. https://doi.org/10.1016/S0304-3940(97)00688-5
  33. Kim Y-H, Nobusawa S, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Vital A, Mariani L, Stawski R, Watanabe T, De Girolami U, Kleihues P, Ohgaki H. Molecular classification of low-grade diffuse gliomas. Am J Pathol. 2010;177(6):2708-2714. https://doi.org/10.2353/ajpath.2010.100680
  34. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol. 2009;174(4):1149-1153. https://doi.org/10.2353/ajpath.2009.080958
  35. Matsko DE, Matsko MV, Imyanitov EN. Neurooncology. Prakticheskaya onkologiya. 2017;18(1):103-114. (In Russ.)
  36. Ahmadi R, Stockhammer F, Becker N, Hohlen K, Misch M, Christians A, Dictus C, Herold-Mende C, Capper D, Unterberg A, von Deimling A, Wick W, Hartmann C. No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas. J Neurooncol. 2012;109(1):15-22. https://doi.org/10.1007/s11060-012-0863-y
  37. Dubbink HJ, Taal W, van Marion R, Kros JM, van Heuvel I, Bromberg JE, Zonnenberg BA, Zonnenberg CBL, Postma TJ, Gijtenbeek JMM, Boogerd W, Groenendijk FH, Smitt PAES, Dinjens WNM, van den Bent MJ. IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide. Neurology. 2009;73(21):1792-1795. https://doi.org/10.1212/WNL.0b013e3181c34ace
  38. Matsko DE, Matsko MV, Ulitin AYu, Imyanitov EN. The new WHO classification of central nervous system tumors (2016) is a challenge to neurosurgeons, neuromorphologists and neurooncologists. Rossiiskii neirokhirurgicheskii zhurnal im. professora A.L. Polenova. 2016;8(3):5-9. (In Russ.)
  39. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He T-C, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih I-M, Theodorescu D, Torbenson MS, Velculescu VE, Wang T-L, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA. 2013;110(15): 6021-6026. https://doi.org/10.1073/pnas.1303607110
  40. Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol. 2013;126(2):267-276. https://doi.org/10.1007/s00401-013-1141-6
  41. Heesters MA, Koudstaal J, Go KG, Molenaar WM. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value. J Neurooncol. 1999;44(3):255-266. https://doi.org/10.1023/A:1006398613605
  42. Paulus W, Grothe C, Sensenbrenner M, Janet T, Baur I, Graf M, Roggendorf W. Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropathol. 1990;79(4):418-423. https://doi.org/10.1007/BF00308718
  43. Geranmayeh F, Scheithauer BW, Spitzer C, Meyer FB, Svensson-Engwall A-C, Graeber MB. Microglia in gemistocytic astrocytomas. Neurosurgery. 2007;60(1):159-166. https://doi.org/10.1227/01.NEU.0000249192.30786.67
  44. Bigner SH, Burger PC, Wong AJ, Werner MH, Hamilton SR, Muhlbaier LH, Vogelstein B, Bigner DD. Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol. 1988;47(3):191-205. https://doi.org/10.1097/00005072-198805000-00001
  45. Sahm F, Korshunov A, Schrimpf D, Stichel D, Jones DTW, Capper D, Koelsche C, Reuss D, Kratz A, Huang K, Wefers AK, Schick M, Bewerunge-Hudler M, Mittelbronn M, Platten M, Hänggi D, Jeibmann A, Unterberg A, Herold-Mende C, Pfister SM, Brandner S, Wick W, Deimling A von. Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas. Acta Neuropathol. 2017;133(2):325-327. https://doi.org/10.1007/s00401-016-1657-7
  46. Cavalla P, Dutto A, Piva R, Richiardi P, Grosso R, Schiffer D. Cyclin D1 expression in gliomas. Acta Neuropathol. 1998;95(2):131-135. https://doi.org/10.1007/s004010050776
  47. Walker AJ, Wedam S, Amiri-Kordestani L, Bloomquist E, Tang S, Sridhara R, Chen W, Palmby TR, Fourie Zirkelbach J, Fu W, Liu Q, Tilley A, Kim G, Kluetz PG, McKee AE, Pazdur R. FDA approval of palbociclib in combination with fulvestrant for the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer. Clin Cancer Res. 2016;22(20):4968-4972. https://doi.org/10.1158/1078-0432.CCR-16-0493
  48. Elvidge AR, Martinez-Coll A. Long-term follow-up of 106 cases of astrocytoma, 1928—1939. J Neurosurg. 1956;13(4):230-243. https://doi.org/10.3171/jns.1956.13.4.0230
  49. Kros JM, Waarsenburg N, Hayes DP, Hop WC, van Dekken H. Cytogenetic analysis of gemistocytic cells in gliomas. J Neuropathol Exp Neurol. 2000;59(8):679-686. https://doi.org/10.1093/jnen/59.8.679
  50. Nowak-Sadzikowska J, Gliński B, Szpytma T, Pluta E. Postoperative irradiation of incompletely excised gemistocytic astrocytomas. Clinical outcome and prognostic factors. Strahlenther Onkol. 2005;181(4):246-250. https://doi.org/10.1007/s00066-005-1305-y
  51. Simkin PM, Yang N, Tsui A, Kalnins RM, Fitt G, Gaillard F. Magnetic resonance imaging features of gemistocytic astrocytoma. J Med Imaging Radiat Oncol. 2016;60(6):733-740. https://doi.org/10.1111/1754-9485.12550
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.